Mr Robert Goodfellow CChem (MRSC) RTTP
Robert Goodfellow, Director of 511 Innovation and Royal Society Entrepreneur in Residence at Edinburgh Napier University is the Commercial Champion of the PlusPEP project. With a career spanning almost 20 years in Industry and academia, Robert spent time within Industrial R&D developing thin film coatings for the Laminated Board, Metalised Paper, & Film / Foil packaging industry before a switch to University. A second career as Technology Transfer Officer (TTO), Knowledge Exchange (KE) Manager and latterly as Head of Enterprise & Business Development in a leading Scottish Technological University underpins Five Eleven Innovation core capability within research commercialisation, Innovation management, UK and EU funding bid development, start-up and spinout.
Dr Craig Stevens BSc (Hons) PhD FHEA
Dr Craig Stevens BSc PhD FHEA is Associate Professor and Principal Investigator (PI) within the School of Applied Sciences at Edinburgh Napier University. Research in Craig’s group is focused upon three main areas:
1. Understanding the role of autophagy in CD.
2. Investigating the mechanism of action of drugs commonly used to treat patients with IBD.
3. The role of host defence peptides in IBD.
Professor Peter G Barlow BSc (Hons) PhD FHEA FRSB
Professor Peter Barlow BSc (Hons) PhD FHEA FRSB is Chair of Immunology and Infection within the School of Applied Sciences at Edinburgh Napier University, Scotland, UK. Professor Barlow’s research interests lie in studying the human innate immune system with a view to developing novel therapeutics for infections. He is particularly interested in studying the activities of Host Defence Peptides (HDP), principally in the context of viral infections, such as influenza and rhinovirus, as well as the Flaviviridae, Dengue Virus. Host Defence Peptides, also known as antimicrobial peptides, are key components of the immune response. These peptides have been shown to display a broad spectrum of antimicrobial and immunomodulatory activities and, as such, are exciting targets for novel therapeutics.
Peter's staff profile page at Edinburgh Napier University